SUSR.F logo

Surgical Science Sweden OTCPK:SUSR.F Stock Report

Last Price

US$13.95

Market Cap

US$726.3m

7D

0%

1Y

n/a

Updated

02 May, 2024

Data

Company Financials +

Surgical Science Sweden AB (publ)

OTCPK:SUSR.F Stock Report

Market Cap: US$726.3m

SUSR.F Stock Overview

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally.

SUSR.F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Surgical Science Sweden AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Surgical Science Sweden
Historical stock prices
Current Share Pricekr13.95
52 Week Highkr18.40
52 Week Lowkr11.84
Beta0.93
1 Month Change-2.45%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-0.59%

Recent News & Updates

Recent updates

Shareholder Returns

SUSR.FUS Medical EquipmentUS Market
7D0%-0.3%0.3%
1Yn/a-0.6%24.2%

Return vs Industry: Insufficient data to determine how SUSR.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how SUSR.F performed against the US Market.

Price Volatility

Is SUSR.F's price volatile compared to industry and market?
SUSR.F volatility
SUSR.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.6%
Market Average Movement6.1%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: SUSR.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SUSR.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997260Gisli Hennermarkwww.surgicalscience.com

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room.

Surgical Science Sweden AB (publ) Fundamentals Summary

How do Surgical Science Sweden's earnings and revenue compare to its market cap?
SUSR.F fundamental statistics
Market capUS$726.28m
Earnings (TTM)US$21.47m
Revenue (TTM)US$81.02m

34.3x

P/E Ratio

9.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SUSR.F income statement (TTM)
Revenuekr882.85m
Cost of Revenuekr269.97m
Gross Profitkr612.88m
Other Expenseskr378.91m
Earningskr233.97m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 15, 2024

Earnings per share (EPS)4.59
Gross Margin69.42%
Net Profit Margin26.50%
Debt/Equity Ratio0%

How did SUSR.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.